NEW YORK (GenomeWeb News) – Fluidigm said in its Form 10-Q last week that it will pay Life Technologies $1.0 million as part of a cross-license agreement reached between Fluidigm and Life Tech's Applied Biosystems business. Life Tech notified Fluidigm in mid-October that the payment is due and payable under the license agreement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.